A prospective, randomized, double-blind parallel-arm, placebo-controlled study to assess the effects on ovarian activity of a combined oral contraceptive pill when preceded by the intake of ellaOne (ulipristal acetate 30 mg) or placebo.
Phase of Trial: Phase IV
Latest Information Update: 24 Jul 2017
At a glance
- Drugs Ulipristal (Primary) ; Ethinylestradiol/levonorgestrel
- Indications Pregnancy
- Focus Pharmacodynamics
- Sponsors HRA Pharma
- 30 Mar 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health).
- 16 Mar 2012 Planned end date added as 1 Apr 2013 as reported by European Clinical Trials Database.
- 28 Feb 2012 New trial record